Depression Promotes the Onset of Irritable Bowel Syndrome through Unique Dysbiosis in Rats = Depression Promotes the Onset of Irritable Bowel Syndrome through Unique Dysbiosis in Rats

다국어 초록 (Multilingual Abstract)

Background/Aims: Although studies using conventional animal models have shown that specific stressors cause irritable bowel syndrome (IBS), it is unclear whether depression itself causes IBS. Our aim was to establish a rat model to determine if depression itself promotes the onset of IBS and to elucidate the role of gut microbiota in brain-gut axis pathogenesis during coincident depression and IBS. Methods: Rat models of depression were induced using our shuttle box method of learned helplessness. Visceral hypersensitivity was evaluated by colorectal distension (CRD) to diagnose IBS. Gut microbiota compositions were analyzed using high-throughput sequencing. In the subanalysis of rats without depression-like symptoms, rats with posttraumatic stress disorder (PTSD) were also examined. Results: The threshold value of CRD in depressed rats was significantly lower than that in control rats. Microbial community analysis of cecal microbiota showed that the relative abundance of Clostridiales incertae sedis, the most prevalent microbe, was significantly lower in depressed rats than in control rats. The distribution pattern of the microbiota clearly differed between depressed rats and control rats. Neither visceral hypersensitivity nor the composition of gut microbiota was altered in rats with PTSD-like phenotypes. Conclusions: Our rat model of depression is useful for clarifying the effect of depression on IBS and suggests that depression itself, rather than specific stressors, promotes the onset of IBS. Further, we provided evidence that various psychiatric diseases, viz., depression and PTSD, are associated with unique gut microbiota profiles, which could differentially affect the onset and progression of coincident IBS. (Gut Liver 2019;13:325-332)

참고문헌 (Reference)

1 Yu M, "Variations in gut microbiota and fecal metabolic phenotype associated with depression by 16S rRNA gene sequencing and LC/MS-based metabolomics" 138 : 231-239, 2017

2 Caporaso JG, "Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms" 6 : 1621-1624, 2012

3 Kelly JR, "Transferring the blues : depression-associated gut microbiota induces neurobehavioural changes in the rat" 82 : 109-118, 2016

4 Koloski NA, "The brain: gut pathway in functional gastrointestinal disorders is bidirectional. A 12-year prospective population-based study" 61 : 1284-1290, 2012

5 Wakizono T, "Stress vulnerabilities in an animal model of post-traumatic stress disorder" 90 : 687-695, 2007

6 Kikuchi A, "Relationship between posttraumatic stress disorder-like behavior and reduction of hippocampal 5-bromo-2’-deoxyuridine-positive cells after inescapable shock in rats" 62 : 713-720, 2008

7 Caporaso JG, "QIIME allows analysis of high-throughput community sequencing data" 7 : 335-336, 2010

8 Pinto-Sanchez MI, "Probiotic Bifidobacterium longum NCC3001 reduces depression scores and alters brain activity : a pilot study in patients with irritable bowel syndrome" 153 : 448-459, 2017

9 Aizawa E, "Possible association of Bifidobacterium and Lactobacillus in the gut microbiota of patients with major depressive disorder" 202 : 254-257, 2016

10 Koba T, "Persistent behavioural changes in rats following inescapable shock stress : a potential model of posttraumatic stress disorder" 2 : 34-37, 2001

11 Kanazawa M, "Patients and nonconsulters with irritable bowel syndrome reporting a parental history of bowel problems have more impaired psychological distress" 49 : 1046-1053, 2004

12 Jinno S, "Maternal prebiotic ingestion increased the number of fecal bifidobacteria in pregnant women but not in their neonates aged one month" 9 : E196-, 2017

13 Ludidi S, "Markers for visceral hypersensitivity in patients with irritable bowel syndrome" 26 : 1104-1111, 2014

14 Keszthelyi D, "Irritable bowel syndrome:methods, mechanisms, and pathophysiology. Methods to assess visceral hypersensitivity in irritable bowel syndrome" 303 : G141-G154, 2012

15 Gwee KA, "Irritable bowel syndrome in Asia : pathogenesis, natural history, epidemiology, and management" 33 : 99-110, 2018

16 Fung TC, "Interactions between the microbiota, immune and nervous systems in health and disease" 20 : 145-155, 2017

17 Tap J, "Identification of an intestinal microbiota signature associated with severity of irritable bowel syndrome" 152 : 111-123, 2017

18 Mosca A, "Gut microbiota diversity and human diseases : should we reintroduce key predators in our ecosystem" 7 : 455-, 2016

19 Dalziel JE, "Gastroparesis and lipid metabolism-associated dysbiosis in Wistar-Kyoto rats" 313 : G62-, 2017

20 Zhang L, "Exogenous interleukin-6 facilitated the contraction of the colon in a depression rat model" 58 : 2187-2196, 2013

21 Takahashi T, "Environmental enrichment enhances autophagy signaling in the rat hippocampus" 1592 : 113-123, 2014

22 Overmier JB, "Effects of inescapable shock upon subsequent escape and avoidance responding" 63 : 28-33, 1967

23 Sawamura T, "Effect of paroxetine on a model of posttraumatic stress disorder in rats" 357 : 37-40, 2004

24 Labus JS, "Differences in gut microbial composition correlate with regional brain volumes in irritable bowel syndrome" 5 : 49-, 2017

25 Musty RE, "Criterion for learned helplessness in the rat : a redefinition" 36 : 739-744, 1990

26 Grenham S, "Brain-gut-microbe communication in health and disease" 2 : 94-, 2011

27 Park AJ, "Altered colonic function and microbiota profile in a mouse model of chronic depression" 25 : 733-, 2013

28 Rodiño-Janeiro BK, "A review of microbiota and irritable bowel syndrome : future in therapies" 35 : 289-310, 2018

29 Al-Chaer ED, "A new model of chronic visceral hypersensitivity in adult rats induced by colon irritation during postnatal development" 119 : 1276-1285, 2000

30 Lima-Ojeda JM, ""I am I and my bacterial circumstances" : linking gut microbiome, neurodevelopment, and depression" 8 : 153-, 2017